Global Coalition For Adaptive Research Inc
- Assets
- $28.3m
- Revenue
- $15.9m
- Investments
- $0.0
- Employees
- 13
- Location
- Larkspur, CA
- Founding
- 04/2018
- Data as of
- 12/2020
- EIN
- 82-1199380
Organization Overview
Global Coalition For Adaptive Research Inc is located in Larkspur, CA. The organization was established in 2018. According to its NTEE Classification (H48) the organization is classified as: Brain Disorders Research, under the broad grouping of Medical Research and related organizations. As of 12/2020, Global Coalition For Adaptive Research Inc employed 13 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Global Coalition For Adaptive Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
TO PROMOTE AND ADVANCE SCIENTIFIC RESEARCH FOR PLATFORM CLINICAL TRIALS FOR RARE DISEASES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
GBM AGILE (GLIOBLASTOMA ADAPTIVE GLOBAL INNOVATIVE LEARNING ENVIRONMENT) IS UNIQUELY DESIGNED AS A LONG-STANDING PLATFORM WITH THE ABILITY TO TEST MULTIPLE THERAPIES AT THE SAME TIME AGAINST A COMMON CONTROL (OR STANDARD OF CARE). THE PURPOSE IS TO EVALUATE MULTIPLE INVESTIGATIONAL TREATMENTS FOR EITHER NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA TO DETERMINE IF ANY OF THESE STUDY TREATMENT(S) IMPROVE OVERALL SURVIVAL AS COMPARED TO STANDARD TREATMENTS.
REMAP-COVID THE OBJECTIVE OF REMAP-COVID IS TO REDUCE MORTALITY AND MORBIDITY IN PATIENTS HOSPITALIZED WITH COVID-19 INFECTION BY QUICKLY GENERATING NEW EVIDENCE ON AVAILABLE AND NOVEL TREATMENTS. THROUGH PARTNERSHIPS WITH ACADEMIA, INDUSTRY AND MULTIPLE HEALTHCARE SYSTEMS, GCAR IS SPONSORING REMAP-COVID IN THE US WITH THE UNIVERSITY OF PITTSBURGH SERVING AS THE US REGIONAL COORDINATING CENTER FOR REMAP-CAP.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Meredith Buxton CEO | Officer | 40 | $434,750 |
Ashley Powell Senior Director Of Trial Operations | 40 | $174,000 | |
Robert Murray Chief Business Officer | 40 | $130,277 | |
Gary Gordon President | OfficerTrustee | 1 | $65,000 |
Timothy Cloughesy MD Director | Trustee | 1 | $60,000 |
Sujan Ba PHD Secretary | OfficerTrustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Berry Consultants Clinical Research | 12/30/20 | $646,050 |
Iqvia Clinical Research | 12/30/20 | $6,912,811 |
Medidata Clinical Research | 12/30/20 | $417,880 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $75,837 |
| All other contributions, gifts, grants, and similar amounts not included above | $289,935 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $365,772 |
| Total Program Service Revenue | $15,491,428 |
| Investment income | $5,866 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $15,863,066 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $250,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $584,412 |
| Compensation of current officers, directors, key employees. | $154,306 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $780,068 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $40,315 |
| Payroll taxes | $82,227 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $216,978 |
| Fees for services: Accounting | $55,864 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $8,039,653 |
| Advertising and promotion | $0 |
| Office expenses | $62,440 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $32,648 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $81,423 |
| All other expenses | $226,217 |
| Total functional expenses | $10,452,245 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $28,140,238 |
| Savings and temporary cash investments | $127,365 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $41,986 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $28,309,589 |
| Accounts payable and accrued expenses | $1,341,423 |
| Grants payable | $0 |
| Deferred revenue | $20,190,909 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,500,000 |
| Total liabilities | $23,032,332 |
| Net assets without donor restrictions | $5,277,257 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $28,309,589 |
Grants Recieved
Over the last fiscal year, we have identified 1 grants that Global Coalition For Adaptive Research Inc has recieved totaling $250,000.
| Awarding Organization | Amount |
|---|---|
Cancer Research America Nfcr Inc Rockville, MD PURPOSE: RESEARCH CONTRACTS | $250,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Global Coalition For Adaptive Research Inc Larkspur, CA | $28,309,589 | $15,863,066 |
Pacific Pediatric Neuro-Oncology Consortium Foundati San Rafael, CA | $273,589 | $1,042,173 |
Childrens Brain Disease Foundation San Francisco, CA | $9,431,635 | $891,755 |
Brain Rehabilitation And Injury Network Cypress, CA | $954,176 | $500,310 |
National Organization Of Disorders Of The Corpus Callosum Yorba Linda, CA | $472,514 | $197,851 |
Karlsson Foundation For Psychoanalysis Campbell, CA | $416,280 | $266,864 |
Brain Mapping Medical Research Organization Los Angeles, CA | $812,547 | $311,275 |
Centre For Neuro Skills - Clinical Research & Education Foundation Bakersfield, CA | $161,106 | $0 |
International Research Consortium For The Corpus Callosum And Pasadena, CA | $28,494 | $0 |
Chiari Project Santa Monica, CA | $35,963 | $0 |
Irvine Head And Neck Research Foundation Anaheim, CA | $267,744 | $92,691 |
Brain Health And Research Foundation Costa Mesa, CA | $0 | $0 |